Skip to main navigation
Skip to search
Skip to main content
Technical University of Munich Home
Help & FAQ
Link opens in a new tab
English
Deutsch
Search content at Technical University of Munich
Home
Profiles
Research units
Projects
Research output
Equipment
Prizes
Activities
Press/Media
Cancer Stem Cells in Pheochromocytoma and Paraganglioma
Laura D. Scriba
, Stefan R. Bornstein
, Alice Santambrogio
, Gregor Mueller
, Angela Huebner
,
Julia Hauer
, Andreas Schedl
, Ben Wielockx
, Graeme Eisenhofer
, Cynthia L. Andoniadou
, Charlotte Steenblock
Universitätsklinikum Carl Gustav Carus Dresden
King's College London
UMR 7271
Research output
:
Contribution to journal
›
Review article
›
peer-review
23
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Cancer Stem Cells in Pheochromocytoma and Paraganglioma'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Cancer Stem Cells
100%
Pheochromocytoma
100%
Paraganglioma
100%
Tumor
33%
Chromaffin Cells
33%
Self-renewal
16%
Stem Cells
16%
Gene mutation
16%
Cardiovascular Morbidity
16%
Somatic mutation
16%
Germline mutation
16%
Breast Cancer
16%
Malignant Tumor
16%
Cancer Development
16%
Surgical Resection
16%
Tumor Recurrence
16%
Cell Signaling Pathways
16%
Colon Cancer
16%
Dedifferentiation
16%
Current Therapies
16%
Targeted Therapeutics
16%
Solid Tumors
16%
Tumor Growth
16%
Metastatic Tumor
16%
Cancer Progression
16%
Recurrent Tumor
16%
Stem Cell Niche
16%
Risk of Malignancy
16%
Inherent Ability
16%
Embryogenesis
16%
Neuroendocrine Tumor
16%
Anticancer Therapeutics
16%
Tumorigenic Process
16%
Brain Cancer
16%
Tumor Persistence
16%
Cardiovascular Variables
16%
De-capacity
16%
Cancer Therapeutic Strategy
16%
Targeting Cancer Stem Cells
16%
Tumor-associated
16%
Cell Tumor
16%
Neuroblastoma Cancer
16%
Medicine and Dentistry
Cancer Stem Cell
100%
Pheochromocytoma
100%
Paraganglioma
100%
Tumor
42%
Malignant Neoplasm
28%
Cardiovascular System
14%
Neoplasm
14%
Recurrent Disease
14%
Germline Mutation
14%
Somatic Mutation
14%
Cancer
14%
Breast Cancer
14%
Metastatic Carcinoma
14%
Tumor Recurrence
14%
Tumor Progression
14%
Cancer Growth
14%
Cell Dedifferentiation
14%
Stem Cell
14%
Solid Malignant Neoplasm
14%
Gene Mutation
14%
Ganglioneuroblastoma
14%
Stem Cell Niche
14%
Embryo Development
14%
Neuroendocrine Tumor
14%
Colon Carcinoma
14%
Chromaffin Cell
14%
Brain Cancer
14%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Pheochromocytoma
100%
Paraganglioma
100%
Solid Malignant Neoplasm
11%
Breast Cancer
11%
Tumor Growth
11%
Cancer Growth
11%
Recurrent Disease
11%
Colon Carcinoma
11%
Tumor Recurrence
11%
Neuroendocrine Tumor
11%
Neuroblastoma
11%
Brain Cancer
11%
Neoplasm
11%